Company Overview

Founded in 1990, CGF Pharmatech Inc. first developed its capacities to distribute and market third-party pharmaceutical and biological products, mostly in the areas of organ transplantation and vaccines. The expertise developed by the company includes mass distribution of temperature-sensitive products (more than 5 million doses of vaccines distributed in 1992 and 1993 on behalf of the Ministre de la Sant du Qubec), as well as controlled distribution of specialty products (clinical trial materials, drugs distributed under the Emergency Drug Regulations). The company has developed a significant niche market for vaccines (private medical clinics and pharmacies), and for immuno-suppressive globulins used for organ transplantation.

Since 1992, CGF Pharmatech Inc. develops and markets dedicated software applications for the management of inventories and controlled distribution of Clinical Trial materials, for the management of vaccines inventories in public health units, and for the management of commercial activities of small to medium sized biotech and pharma companies.

FACILITIES:

3000 cubic feet of refrigerated space (2-8C). 100 cubic feet of deep-freeze space (below -20C). 1500 sq. ft. storage facility. The refrigerated and deep-freeze equipment are fully equipped with electronic monitoring and alarm devices, as well as emergency power back-up.

BUSINESS STRATEGY:

Expansion of the product line through distribution agreements (exclusive and non-exclusive), including products for research and clinical laboratories. Market expansion for the software applications, with an emphasis on the products for the control of Clinical Trial Materials distribution on the North-American and European markets. Development of the in-house R&D program (described below).

RESEARCH & DEVELOPMENT:

In 1992, CGF Pharmatech Inc. initiated the development of a software application for advanced determination of immunological properties of protein domains. This R&D program, based on previous successes in the area of HIV immunology, is most particularly aimed at identification of sequences responsible for major side-effects in some human vaccines.

Company Information

Additional Details

Legal Name: CGF Pharmatech inc.

Contacts

Services

• Biotechnology
• Software Applications

  Software applications for public health units, for medical departments of pharmaceutical companies, and for biotech companies.

Products

• Immuno-suppressive Globulins
• Vaccines

Additional Information